Tenaya Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $278.5M | $38.1M |
| FY2022 | — | $243.4M | $95.3M |
| FY2023 | — | $139.4M | $45.7M |
| FY2024 | — | $92.9M | $4.3M |
| FY2025 | — | $123.3M | $100.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $278.5M | $38.1M |
| FY2022 | — | $243.4M | $95.3M |
| FY2023 | — | $139.4M | $45.7M |
| FY2024 | — | $92.9M | $4.3M |
| FY2025 | — | $123.3M | $100.5M |